Welcome to MyIDSA

Welcome to MyIDSA, IDSA’s Member-Only Community! Connect with Colleagues, Share Resources, Start or Join a Lively Discussion. Join us…It’s Infectious!


Recent Discussions

  • Profile Picture

    Remembering Bob Rubin

    Posted in: IDea Exchange

    Best known for his contributions in transplant ID -- a field he practically created -- Bob Rubin was also very different from most of us ID doctors. Here's a tribute to this remarkable man. Paul ------------------------------ Paul E. Sax MD Brigham ...

  • Posted in: HIV Community

    ​I have also had good experiences with the Univ of Washington lab's universal PCR for similar patients ------------------------------ Lawrence Livornese MD FIDSA, FACP Chairman, Department of Medicine, Main Line Health Delaware Valley I.D. Associates, ...

  • Posted in: HIV Community

    I agree with your assessment to advise the patient not to donate. The loss of GFR is exponential so the rise in the serum creatinine in this case is not insignificant. I expect the patient would be rejected at screening even if he were to go ahead with ...

New Guidelines Update

IDSA, ASTMH Neurocysticercosis Guideline


Practice Guidelines

Member Spotlight

Kim Hanson, MD

IDSA Diagnostics Committee Chair Kim Hanson, MD, has been appointed to the Centers for Medicare and Medicaid (CMS) Advisory Panel on Clinical Diagnostic Laboratory Tests following a nomination from IDSA. The Panel advises the CMS Administrator and the Secretary of the Department of Health and Human Services on issues related to clinical diagnostic laboratory tests, including the establishment of payment rates and the factors used in determining coverage and payment processes for new tests.

Dr. Hanson is the head of Immunocompromised Host Infectious Diseases Services and Director of the Medical Microbiology Fellowship Program at the University of Utah, as well as Director of Clinical Microbiology at ARUP Laboratories. She is an associate professor of medicine and pathology, splitting her time between patient care, laboratory administration, research, and teaching.


  • 10 years after a rejection, Merck returns to the FDA with a Gardasil 9 age expansion bid

    How long is a drugmaker willing to wait on an indication expansion plan? For Merck’s HPV vaccines, that's 10 years.
  • An HIV physician talks about heroin, harm reduction and political will in the heartland

    Two epidemics, fueled by stigma and allowed to flourish amidst political neglect, set the course of Dr. Judith Feinberg’s professional life.

Help attract the best and brightest to the field of infectious diseases.

IDSA Foundation

Upcoming Events

  • Wednesday

    IDWeek 2018

    Wednesday, October 3 - Sunday, October 7, 2018
    Registration will open for members on March 6, and to everyone on April 3.
    San Francisco, CA, United States

IDSA has been important in my career in infectious disease. IDSA also plays a big role in advocacy and drawing attention to key issues. It's exciting to be a part of that and feel that I have an avenue for my voice to be heard.
Ingrid Bassett, MD, MPH, FIDSA
The idea that I could link epidemiology with my fundamental knowledge of how microorganisms work, along with diagnostic microbiology...this is an amazing way to put the pieces of the puzzles together about how infectious diseases work in human beings.
Lucy Tompkins, MD, PhD, FIDSA
I always like mystery stories growing up and you have to be very astute...You have to look at the symptoms, the geography, the home and social situation to solve the mystery of their problem.
Susan Bleasdale, MD
You can take a patient in front of you, and within a short amount of time with your clinical care, have an enormous impact.
John Lynch, MD, MPH
Understanding the pathogenesis of infectious diseases requires a knowledge of pathology, immunology, especially microbiology. The discipline allows practitioners to combine all of those, and there's never a dull moment.
Philip Polgreen, MD, MPH
I just became a member of IDSA this year, and I find it amazing how supportive IDSA has been to me so far.
Noah Kojima, MD